Literature DB >> 7086003

The evaluation of occupational airways disease in the laboratory and workplace.

S M Brooks.   

Abstract

Occupational immunologic lung disease can be identified both in the individual patient under laboratory conditions and in a population of workers in industry. Occupational airways disorder is the most common occupational immunologic pulmonary process and is a disease of the airways caused by the inhalation of a substance or material that the worker manufactures or uses directly or that is incidentally present at the worksite. There are several occupational airways disorders, including industrial bronchitis, occupational asthma, and reactive airways disease syndrome, the latter two of which will be discussed more thoroughly. Occupational asthma can be appropriately identified when the following are present (1) typical symptoms, i.e., wheeze, cough, shortness of breath, and/or chest tightness; (2) specific identification of the offending agent; (3) documentation that the agent can cause asthma; (4) wheezes on physical examination; (5) pulmonary function changes; (6) immunologic abnormalities; (7) airway hyperreactivity; and (8) positive bronchial challenge with specific material. The diagnosis of occupational airways disorder requires a comprehensive approach, including clinical history, physiologic measurements, immunologic testing, and identification of airway hyperreactivity. By this approach both individual subjects and working populations can be studied.

Entities:  

Mesh:

Year:  1982        PMID: 7086003     DOI: 10.1016/0091-6749(82)90202-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  Recurrent asthma induced by toluene diisocyanate.

Authors:  D E Banks; R J Rando
Journal:  Thorax       Date:  1988-08       Impact factor: 9.139

Review 2.  Environmental control of the workplace.

Authors:  H S Novey
Journal:  Clin Rev Allergy       Date:  1988

3.  Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives.

Authors:  O Vandenplas; J L Malo; M Saetta; C E Mapp; L M Fabbri
Journal:  Br J Ind Med       Date:  1993-03

4.  Comparison of airway reactivity induced by histamine, methacholine, and isocapnic hyperventilation in normal and asthmatic subjects.

Authors:  A T Aquilina
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

5.  Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD.

Authors:  Mark T Dransfield; Andrew M Wilhelm; Brian Flanagan; Clifford Courville; Sherry L Tidwell; S Vamsee Raju; Amit Gaggar; Chad Steele; Li Ping Tang; Bo Liu; Steven M Rowe
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

6.  Toluene diisocyanate increases airway responsiveness to substance P and decreases airway neutral endopeptidase.

Authors:  D Sheppard; J E Thompson; L Scypinski; D Dusser; J A Nadel; D B Borson
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

7.  The antibody response to methyl isocyanate: experimental and clinical findings.

Authors:  M H Karol; S Taskar; S Gangal; B F Rubanoff; S R Kamat
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

8.  Allergic reactions to indoor air pollutants.

Authors:  M H Karol
Journal:  Environ Health Perspect       Date:  1991-11       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.